PANE, FABRIZIO
PANE, FABRIZIO
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
DIRECT-DETECTION OF PROVIRAL GAG SEGMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS IN PERIPHERAL-BLOOD LYMPHOCYTES BY COLORIMETRIC PCR ASSAY AS A CLINICAL LABORATORY TOOL APPLIED TO DIFFERENT AT-RISK POPULATIONS
1995 Pane, Fabrizio; Butto, S.; Gobbo, M. L.; Franco, M.; Butteroni, C.; Pastore, Lucio; Maiorano, G.; Foggia, M.; Cataldo, P. T.; Guarino, A.; Tamburrini, E.; Solinas, S.; Piazza, M.; Vecchio, Giancarlo; Verani, P.; Salvatore, Francesco
In vitro acquired cellular senescence and aging specific phenotype can be distinguished on the basis of specific mRNA expression.
2002 Faraonio, Raffaella; Pane, Fabrizio; Intrieri, M.; Russo, Tommaso; Cimino, F.
In vitro acquired cellular senescence and aging-specific phenotype can be distinguished on the basis of specific mRNA expression
2002 Faraonio, Raffaella; Pane, Fabrizio; Intrieri, M; Russo, T; AND CIMINO, F.
Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two cases.
2004 F., Ferrara; Selleri, Carmine; G., Mele; Serio, Bianca; S., Palmieri; B., Pocali; Pane, Fabrizio; Rotoli, Bruno
CHRONIC GRAFT Vs HOST DISEASE OF THE GENITAL TRACT: DIAGNOSIS, CLINICAL IMPACT AND MANAGEMENT FROM SURVEILLANCE PROGRAM IN A PRELIMINARY COHORT
2013 Marotta, Serena; Ricciardi, D.; Bertrando, A.; de Rosa, N.; Pagliuca, Simona; Basile, Santina; Cardano, F.; Pane, Fabrizio; DE ROSA, Gennaro; Piccoli, R.; Risitano, ANTONIO MARIA
Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis.
2010 Castagnetti, F; Testoni, N; Luatti, S; Marzocchi, G; Mancini, M; Kerim, S; Giugliano, E; Albano, F; Cuneo, A; Abruzzese, E; Martino, B; Palandri, F; Amabile, M; Iacobucci, I; Alimena, G; Pane, Fabrizio; Martinelli, G; Saglio, G; Baccarani, M; Rosti, G.
Efficacy and safety of rituximab treatment in patients with progressive transformation of germinal centers after Hodgkin lymphoma in complete remission post-induction chemotherapy and radiotherapy.
2011 Picardi, Marco; Zeppa, P; Ciancia, G; Pettinato, G; Grimaldi, F; Fabbricini, R; Mainolfi, C; Pane, Fabrizio
Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan.
2010 Ferrara, F; Izzo, T; Criscuolo, C; Riccardi, C; Muccioli, G; Viola, A; Pane, Fabrizio; Palmieri, S.
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.
2010 Saglio, G; Kim, Dw; Issaragrisil, S; le Coutre, P; Etienne, G; Lobo, C; Pasquini, R; Clark, Re; Hochhaus, A; Hughes, Tp; Gallagher, N; Hoenekopp, A; Dong, M; Haque, A; Larson, Ra; Kantarjian, Hm; Moiraghi, B; Perez, M; Greil, R; Valent, P; Bosly, A; Martiat, P; Noens, L; André, M; Verhoef, G; Conchon, M; Souza, C; Nonino, A; Hungria, V; Zanichelli, Ma; Colturato, V; Forrest, D; Lipton, Jh; Savoie, Ml; Delage, R; Lalancette, M; Quintero, G; Gomez, M; Klamova, H; Faber, E; Bjerrum, Ow; Fredriksen, H; Vestergaard, H; Marcher, C; Kamel, H; Elzawam, H; Porkka, K; Remes, K; Reiffers, J; Guilhot, F; Facon, T; Tulliez, M; Guerci Bresler, Ap; Nicolini, Fe; Charbonnier, A; Rea, D; Johnson Ansah, A; Legros, L; Harousseau, Jl; Rigal Huguet, F; Escoffre, M; Gardembas, M; Guyotat, D; Cahn, Jy; Gattermann, N; Ottmann, O; Niederwieser, D; Stegelmann, F; Schafhausen, P; Brümmendorf, T; Duyster, J; Blumenstengel, K; Scheid, C; Kneba, M; Kwong, Yl; Masszi, T; Petrini, M; Alimena, G; Di Raimondo, F; Rosti, G; Rotoli, B; Pane, Fabrizio; Pungolino, E; Amadori, S; Abruzzese, E; Fioritoni, G; Lauria, F; Bosi, A; Martelli, M; Rambaldi, A; Ferrara, F; Nobile, F; Gobbi, M; Carella, Am; Orlandi, Em; Leoni, P; Tiribelli, M; Levis, A; Imamura, M; Takahashi, N; Tsukamoto, N; Chiba, S; Nagai, T; Okamoto, S; Miura, O; Kurokawa, M; Ohnishi, K; Toba, K; Nakao, S; Tomita, A; Miyamura, K; Hino, M; Maeda, Y; Kimura, A; Kawaguchi, T; Miyazaki, Y; Nakaseko, C; Jinnai, I; Matsuda, A; Matsumura, I; Ishikawa, J; Ohyashiki, K; Okada, M; Usuki, K; Kobayashi, Y; Ohishi, K; Imai, K; Miyawaki, S; Kanda, Y; Park, Sy; Kim, Hj; Sohn, Sk; Lee, Kh; Jung, Cw; Ong, Tc; Gómez Almaguer, D; Kassack, J; Ossenkoppele, Gj; Gedde Dahl, T; Hjorth Hansen, H; Jedrzejczak, W; Dmoszynska, A; Starzak Dwozdz, J; Holowiecki, J; Kyrcz Krzemieñ, S; Kuliczkowski, K; Zaritsky, A; Turkina, A; Pospelova, T; Goh, Yt; Koh, Lp; Demitrovicova, L; Mistrik, M; Ruff, P; Louw, V; Dreosti, Lm; Novitzky, N; Cohen, G; Cervantes, F; Cañizo, C; de Paz, R; del Castillo, S; Perez Encinas, M; Sanz Alonso, M; Marin, F; Pérez López, R; Hernandez Boluda, J; Echeveste Gutierrez, Ma; Odriozola, J; Herrera, P; Steegman, Jl; Conde, E; Lopez, P; Giraldo, P; Boque, C; Heredia, B; Font, Aj; Rodriguez, Rf; Rodriguez, Mj; Batlle, J; Stenke, L; Lehmann, S; Wadenvik, H; Simonsson, B; Markevärn, B; Själander, A; Richter, J; Bjoreman, M; Eriksson, Km; Chalandon, Y; Shih, Ly; Yao, M; Wang, Mc; Jootar, S; Bunworasate, U; Ulkü, B; Haznedar, R; Undar, B; Sahin, B; Marin, D; Smith, G; Byrne, J; Holyoake, T; Kalaycio, M; Akard, L; Heaney, M; Al Janadi, A; Goldberg, S; Powell, B; Harker, Wg; Shea, T; Gingrich, R; Glass, J; Paquette, R; Siegrist, C; Woodson, M; Fehrenbacher, L; Koh, H; Flinn, I; Arrowsmith, E; Ervin, T; Guerra, M; Wallach, H; Berry, W; Burke, J; Edenfield, W; Guzley, G; Davis, J; Richards, D; Schlossman, D; Kolibaba, K; Alemany, C; Savin, M; Robbins, G; Lopez, J; Goldman, Jm; Camm, J; Schiffer, Ca; Sargent, D. J.
Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib.
2011 Breccia, M; Latagliata, R; Stagno, F; Luciano, L; Gozzini, A; Castagnetti, F; Fava, C; Cavazzini, F; Annunziata, M; Russo Rossi, A; Pregno, P; Abruzzese, E; Vigneri, P; Rege Cambrin, G; Sica, S; Pane, Fabrizio; Santini, V; Specchia, G; Rosti, G; Alimena, G.
Preferential nuclear accumulation of JAK2V617F in CD34+ but not in granulocytic, megakaryocytic or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia.
2010 Rinaldi, C. R.; Rinaldi, P.; Alagia, A.; Gemei, M.; Esposito, N.; Formiggini, F.; Martinelli, Vincenzo; Senyuk, V.; Nucifora, G.; Pane, Fabrizio
JURL-MK1 (c-kit(high)/CD30-/CD40-) and JURL-MK2 (c-kit(low)/CD30+/CD40+) cell lines: 'two-sided' model for investigating leukemic megakaryocytopoiesis.
1997 DI NOTO, Rosa; Luciano, Luigia; Lo Pardo, C.; Ferrara, F.; Frigeri, F.; Mercuro, O.; Lombardi, M. L.; Pane, Fabrizio; Vacca, C.; Manzo, C.; Salvatore, Francesco; Rotoli, Bruno; DEL VECCHIO, Luigi
Simultaneous occurrence of tetrasomy 21 and trisomy 8 in a patient with early blastic metamorphosis of chronic myeloproliferative disorder.
1995 Sebastio, L.; Ferrara, F.; Vicari, L.; DI NOTO, Rosa; DEL VECCHIO, Luigi; Pane, Fabrizio; Fasanaro, A.; Cimino, R.; Salvatore, Francesco; Ventruto, V.
Trisomy 13 in a case of myelofibrosis with myeloid metaplasia with early blastic transformation.
1995 Ferrara, F.; Vicari, L.; Festa, B.; DI NOTO, Rosa; Pane, Fabrizio; Sebastio, L.; Cimino, R.
Specific messanger RNA as indicators of neoplasia.
2000 Salvatore, F.; Sacchetti, L.; Castaldo, Giuseppe; Pane, Fabrizio
Decitabine up-regulates the expression of the cancer-associate prame antigen in early chronic phase CML cells.
2003 Pane, Fabrizio; Quintarelli, Concetta; Izzo, Barbara; Martinelli, G.; Intrieri, M.; Luciano, L.; Amabile, M.; Rosti, G.; Saglio, G.; Baccarani, M.; Salvatore, F.
CIRCULATING MEGAKARYOCYTE-DERIVED CELLS DETECTED BY FLOW CYTOMETRY AS MARKER OF AGGRESSIVE NEOPLASM OF MEGAKARYOCYTIC LINEAGE IN ACUTE MEGAKARYOBLASTIC LEUKEMIA AND ALLIED MALIGNANCIES PRESENTING AS PRIMARY MYELOFIBROSIS
2012 Marotta, Serena; Giagnuolo, Giovanna; Scalia, Giulia; Raia, M.; Basile, Santina; Ciancia, Giuseppe; Pettinato, Guido; Pane, Fabrizio; DE ROSA, Gennaro; DEL VECCHIO, Luigi; Risitano, ANTONIO MARIA
The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase.
2010 Palandri, F; Castagnetti, F; Iacobucci, I; Martinelli, G; Amabile, M; Gugliotta, G; Poerio, A; Testoni, N; Breccia, M; Bocchia, M; Crugnola, M; Rege Cambrin, G; Martino, B; Pierri, I; Radaelli, F; Specchia, G; Pane, Fabrizio; Saglio, G; Rosti, G; Baccarani, M.
Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimization and selectivity study.
2010 Cortes, Je; Baccarani, M; Guilhot, F; Druker, Bj; Branford, S; Kim, Dw; Pane, Fabrizio; Pasquini, R; Goldberg, Sl; Kalaycio, M; Moiraghi, B; Rowe, Jm; Tothova, E; De Souza, C; Rudoltz, M; Yu, R; Krahnke, T; Kantarjian, Hm; Radich, Jp; Hughes, T. P.
PEGYLATED-FILGRASTIM AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION: SINGLE CENTRE EXPERIENCE
2013 Madonna, Emanuela; Grimaldi, Francesco; Avilia, Simona; Giagnuolo, Giovanna; Marotta, Serena; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| DIRECT-DETECTION OF PROVIRAL GAG SEGMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS IN PERIPHERAL-BLOOD LYMPHOCYTES BY COLORIMETRIC PCR ASSAY AS A CLINICAL LABORATORY TOOL APPLIED TO DIFFERENT AT-RISK POPULATIONS | 1.1 Articolo in rivista | 1995 | Pane, Fabrizio; Butto, S.; Gobbo, M. L.; Franco, M.; Butteroni, C.; Pastore, Lucio; Maiorano, G.; Foggia, M.; Cataldo, P. T.; Guarino, A.; Tamburrini, E.; Solinas, S.; Piazza, M.; Vecchio, Giancarlo; Verani, P.; Salvatore, Francesco | |
| In vitro acquired cellular senescence and aging specific phenotype can be distinguished on the basis of specific mRNA expression. | 1.1 Articolo in rivista | 2002 | Faraonio, Raffaella; Pane, Fabrizio; Intrieri, M.; Russo, Tommaso; Cimino, F. | |
| In vitro acquired cellular senescence and aging-specific phenotype can be distinguished on the basis of specific mRNA expression | 1.1 Articolo in rivista | 2002 | Faraonio, Raffaella; Pane, Fabrizio; Intrieri, M; Russo, T; AND CIMINO, F. | |
| Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two cases. | 1.1 Articolo in rivista | 2004 | F., Ferrara; Selleri, Carmine; G., Mele; Serio, Bianca; S., Palmieri; B., Pocali; Pane, Fabrizio; Rotoli, Bruno | |
| CHRONIC GRAFT Vs HOST DISEASE OF THE GENITAL TRACT: DIAGNOSIS, CLINICAL IMPACT AND MANAGEMENT FROM SURVEILLANCE PROGRAM IN A PRELIMINARY COHORT | 1.1 Articolo in rivista | 2013 | Marotta, Serena; Ricciardi, D.; Bertrando, A.; de Rosa, N.; Pagliuca, Simona; Basile, Santina; Cardano, F.; Pane, Fabrizio; DE ROSA, Gennaro; Piccoli, R.; Risitano, ANTONIO MARIA | |
| Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis. | 1.1 Articolo in rivista | 2010 | Castagnetti, F; Testoni, N; Luatti, S; Marzocchi, G; Mancini, M; Kerim, S; Giugliano, E; Albano, F; Cuneo, A; Abruzzese, E; Martino, B; Palandri, F; Amabile, M; Iacobucci, I; Alimena, G; Pane, Fabrizio; Martinelli, G; Saglio, G; Baccarani, M; Rosti, G. | |
| Efficacy and safety of rituximab treatment in patients with progressive transformation of germinal centers after Hodgkin lymphoma in complete remission post-induction chemotherapy and radiotherapy. | 1.1 Articolo in rivista | 2011 | Picardi, Marco; Zeppa, P; Ciancia, G; Pettinato, G; Grimaldi, F; Fabbricini, R; Mainolfi, C; Pane, Fabrizio | |
| Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan. | 1.1 Articolo in rivista | 2010 | Ferrara, F; Izzo, T; Criscuolo, C; Riccardi, C; Muccioli, G; Viola, A; Pane, Fabrizio; Palmieri, S. | |
| Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. | 1.1 Articolo in rivista | 2010 | Saglio, G; Kim, Dw; Issaragrisil, S; le Coutre, P; Etienne, G; Lobo, C; Pasquini, R; Clark, Re; Hochhaus, A; Hughes, Tp; Gallagher, N; Hoenekopp, A; Dong, M; Haque, A; Larson, Ra; Kantarjian, Hm; Moiraghi, B; Perez, M; Greil, R; Valent, P; Bosly, A; Martiat, P; Noens, L; André, M; Verhoef, G; Conchon, M; Souza, C; Nonino, A; Hungria, V; Zanichelli, Ma; Colturato, V; Forrest, D; Lipton, Jh; Savoie, Ml; Delage, R; Lalancette, M; Quintero, G; Gomez, M; Klamova, H; Faber, E; Bjerrum, Ow; Fredriksen, H; Vestergaard, H; Marcher, C; Kamel, H; Elzawam, H; Porkka, K; Remes, K; Reiffers, J; Guilhot, F; Facon, T; Tulliez, M; Guerci Bresler, Ap; Nicolini, Fe; Charbonnier, A; Rea, D; Johnson Ansah, A; Legros, L; Harousseau, Jl; Rigal Huguet, F; Escoffre, M; Gardembas, M; Guyotat, D; Cahn, Jy; Gattermann, N; Ottmann, O; Niederwieser, D; Stegelmann, F; Schafhausen, P; Brümmendorf, T; Duyster, J; Blumenstengel, K; Scheid, C; Kneba, M; Kwong, Yl; Masszi, T; Petrini, M; Alimena, G; Di Raimondo, F; Rosti, G; Rotoli, B; Pane, Fabrizio; Pungolino, E; Amadori, S; Abruzzese, E; Fioritoni, G; Lauria, F; Bosi, A; Martelli, M; Rambaldi, A; Ferrara, F; Nobile, F; Gobbi, M; Carella, Am; Orlandi, Em; Leoni, P; Tiribelli, M; Levis, A; Imamura, M; Takahashi, N; Tsukamoto, N; Chiba, S; Nagai, T; Okamoto, S; Miura, O; Kurokawa, M; Ohnishi, K; Toba, K; Nakao, S; Tomita, A; Miyamura, K; Hino, M; Maeda, Y; Kimura, A; Kawaguchi, T; Miyazaki, Y; Nakaseko, C; Jinnai, I; Matsuda, A; Matsumura, I; Ishikawa, J; Ohyashiki, K; Okada, M; Usuki, K; Kobayashi, Y; Ohishi, K; Imai, K; Miyawaki, S; Kanda, Y; Park, Sy; Kim, Hj; Sohn, Sk; Lee, Kh; Jung, Cw; Ong, Tc; Gómez Almaguer, D; Kassack, J; Ossenkoppele, Gj; Gedde Dahl, T; Hjorth Hansen, H; Jedrzejczak, W; Dmoszynska, A; Starzak Dwozdz, J; Holowiecki, J; Kyrcz Krzemieñ, S; Kuliczkowski, K; Zaritsky, A; Turkina, A; Pospelova, T; Goh, Yt; Koh, Lp; Demitrovicova, L; Mistrik, M; Ruff, P; Louw, V; Dreosti, Lm; Novitzky, N; Cohen, G; Cervantes, F; Cañizo, C; de Paz, R; del Castillo, S; Perez Encinas, M; Sanz Alonso, M; Marin, F; Pérez López, R; Hernandez Boluda, J; Echeveste Gutierrez, Ma; Odriozola, J; Herrera, P; Steegman, Jl; Conde, E; Lopez, P; Giraldo, P; Boque, C; Heredia, B; Font, Aj; Rodriguez, Rf; Rodriguez, Mj; Batlle, J; Stenke, L; Lehmann, S; Wadenvik, H; Simonsson, B; Markevärn, B; Själander, A; Richter, J; Bjoreman, M; Eriksson, Km; Chalandon, Y; Shih, Ly; Yao, M; Wang, Mc; Jootar, S; Bunworasate, U; Ulkü, B; Haznedar, R; Undar, B; Sahin, B; Marin, D; Smith, G; Byrne, J; Holyoake, T; Kalaycio, M; Akard, L; Heaney, M; Al Janadi, A; Goldberg, S; Powell, B; Harker, Wg; Shea, T; Gingrich, R; Glass, J; Paquette, R; Siegrist, C; Woodson, M; Fehrenbacher, L; Koh, H; Flinn, I; Arrowsmith, E; Ervin, T; Guerra, M; Wallach, H; Berry, W; Burke, J; Edenfield, W; Guzley, G; Davis, J; Richards, D; Schlossman, D; Kolibaba, K; Alemany, C; Savin, M; Robbins, G; Lopez, J; Goldman, Jm; Camm, J; Schiffer, Ca; Sargent, D. J. | |
| Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib. | 1.1 Articolo in rivista | 2011 | Breccia, M; Latagliata, R; Stagno, F; Luciano, L; Gozzini, A; Castagnetti, F; Fava, C; Cavazzini, F; Annunziata, M; Russo Rossi, A; Pregno, P; Abruzzese, E; Vigneri, P; Rege Cambrin, G; Sica, S; Pane, Fabrizio; Santini, V; Specchia, G; Rosti, G; Alimena, G. | |
| Preferential nuclear accumulation of JAK2V617F in CD34+ but not in granulocytic, megakaryocytic or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia. | 1.1 Articolo in rivista | 2010 | Rinaldi, C. R.; Rinaldi, P.; Alagia, A.; Gemei, M.; Esposito, N.; Formiggini, F.; Martinelli, Vincenzo; Senyuk, V.; Nucifora, G.; Pane, Fabrizio | |
| JURL-MK1 (c-kit(high)/CD30-/CD40-) and JURL-MK2 (c-kit(low)/CD30+/CD40+) cell lines: 'two-sided' model for investigating leukemic megakaryocytopoiesis. | 1.1 Articolo in rivista | 1997 | DI NOTO, Rosa; Luciano, Luigia; Lo Pardo, C.; Ferrara, F.; Frigeri, F.; Mercuro, O.; Lombardi, M. L.; Pane, Fabrizio; Vacca, C.; Manzo, C.; Salvatore, Francesco; Rotoli, Bruno; DEL VECCHIO, Luigi | |
| Simultaneous occurrence of tetrasomy 21 and trisomy 8 in a patient with early blastic metamorphosis of chronic myeloproliferative disorder. | 1.1 Articolo in rivista | 1995 | Sebastio, L.; Ferrara, F.; Vicari, L.; DI NOTO, Rosa; DEL VECCHIO, Luigi; Pane, Fabrizio; Fasanaro, A.; Cimino, R.; Salvatore, Francesco; Ventruto, V. | |
| Trisomy 13 in a case of myelofibrosis with myeloid metaplasia with early blastic transformation. | 1.1 Articolo in rivista | 1995 | Ferrara, F.; Vicari, L.; Festa, B.; DI NOTO, Rosa; Pane, Fabrizio; Sebastio, L.; Cimino, R. | |
| Specific messanger RNA as indicators of neoplasia. | 4.1 Articoli in Atti di convegno | 2000 | Salvatore, F.; Sacchetti, L.; Castaldo, Giuseppe; Pane, Fabrizio | |
| Decitabine up-regulates the expression of the cancer-associate prame antigen in early chronic phase CML cells. | 1.5 Abstract in rivista | 2003 | Pane, Fabrizio; Quintarelli, Concetta; Izzo, Barbara; Martinelli, G.; Intrieri, M.; Luciano, L.; Amabile, M.; Rosti, G.; Saglio, G.; Baccarani, M.; Salvatore, F. | |
| CIRCULATING MEGAKARYOCYTE-DERIVED CELLS DETECTED BY FLOW CYTOMETRY AS MARKER OF AGGRESSIVE NEOPLASM OF MEGAKARYOCYTIC LINEAGE IN ACUTE MEGAKARYOBLASTIC LEUKEMIA AND ALLIED MALIGNANCIES PRESENTING AS PRIMARY MYELOFIBROSIS | 4.3 Poster | 2012 | Marotta, Serena; Giagnuolo, Giovanna; Scalia, Giulia; Raia, M.; Basile, Santina; Ciancia, Giuseppe; Pettinato, Guido; Pane, Fabrizio; DE ROSA, Gennaro; DEL VECCHIO, Luigi; Risitano, ANTONIO MARIA | |
| The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase. | 1.1 Articolo in rivista | 2010 | Palandri, F; Castagnetti, F; Iacobucci, I; Martinelli, G; Amabile, M; Gugliotta, G; Poerio, A; Testoni, N; Breccia, M; Bocchia, M; Crugnola, M; Rege Cambrin, G; Martino, B; Pierri, I; Radaelli, F; Specchia, G; Pane, Fabrizio; Saglio, G; Rosti, G; Baccarani, M. | |
| Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimization and selectivity study. | 1.1 Articolo in rivista | 2010 | Cortes, Je; Baccarani, M; Guilhot, F; Druker, Bj; Branford, S; Kim, Dw; Pane, Fabrizio; Pasquini, R; Goldberg, Sl; Kalaycio, M; Moiraghi, B; Rowe, Jm; Tothova, E; De Souza, C; Rudoltz, M; Yu, R; Krahnke, T; Kantarjian, Hm; Radich, Jp; Hughes, T. P. | |
| PEGYLATED-FILGRASTIM AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION: SINGLE CENTRE EXPERIENCE | 4.3 Poster | 2013 | Madonna, Emanuela; Grimaldi, Francesco; Avilia, Simona; Giagnuolo, Giovanna; Marotta, Serena; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro |